TC BioPharm Limited Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

FAIR VALUE MEASUREMENTS (Details Narrative)

FAIR VALUE MEASUREMENTS (Details Narrative)	Dec. 18, 2023 USD ($) shares	Aug. 30, 2023 USD ($)	Aug. 30, 2023 GBP (£) £ / shares shares	Jul. 10, 2023 shares	Mar. 27, 2023 $ / shares shares	Nov. 27, 2022 USD ($) $ / shares shares	Jun. 08, 2022 shares	Feb. 10, 2022 USD ($) $ / shares shares	Feb. 10, 2022 GBP (£) shares	Dec. 31, 2023 $ / shares	Dec. 31, 2023 GBP (£) £ / shares	Dec. 18, 2023 £ / shares shares	Apr. 03, 2023 $ / shares	Mar. 30, 2023 $ / shares	Dec. 31, 2022 $ / shares	Dec. 31, 2022 GBP (£)	Aug. 09, 2022 shares	Aug. 25, 2020 £ / shares
Cash and Cash Equivalents, at Carrying Value \| £											£ 2,462,609					£ 4,808,060
Warrants to purchase up					140,000			6,278
Proceeds from warrant exercises		$ 2,800,000	£ 2,200,000
Lowest closing price of ordinary shares \| (per share)													$ 0.20					£ 215.00
Balance, shares							230,000	63,280	63,280
Warrants outstanding																	233,560
Series A Warrant [Member]
Fair value of warrants price per share \| $ / shares										$ 0.37					$ 51.60
Series B Warrant [Member]
Fair value of warrants price per share \| $ / shares										0.01					36.80
Series AB Placement Agent Warrants [Member]
Fair value of warrants price per share \| $ / shares										$ 0.31					$ 51.20
Series C Warrants [Member]
Fair value of warrants price per share \| $ / shares														$ 21.63
Series C Placement Agent Warrants [Member]
Fair value of warrants price per share \| £ / shares											£ 0.69
Series D Warrants [Member]
Fair value of warrants price per share \| £ / shares			£ 8.46
Series D Placement Agent Warrants [Member]
Fair value of warrants price per share \| £ / shares			£ 8.20
Series E Warrants [Member]
Fair value of warrants price per share \| £ / shares												£ 1.97
Series E Placement Agent Warrants [Member]
Fair value of warrants price per share \| £ / shares												£ 1.89
Series A Warrant [Member]
Warrants outstanding			70,000
Series B Warrant [Member]
Warrants outstanding			70,000
Placement Agent Warrants [Member]
Warrants to purchase up			23,391
Series C Warrant [Member]
Warrants outstanding			171,875
Series A, B and C Warrant [Member]
Proceeds from warrant exercises \| £			£ 2,800,000
Series D Warrants [Member]
Warrants to purchase up			623,750
November 2022 Warrant [Member]
Warrants to purchase up				140,000
March 2023 Warrants, November 2022 Warrants and Existing Warrants [Member]
Warrants to purchase up				171,875
Warrant rights description				(i) amend the current exercise price on all Existing Warrants so that it is now equal to £7.00, (ii) extend the termination date on 50% of the November 2022 Warrants and all of the March 2023 Warrants until May 30, 2028 and (iii) amend to the definition of “Black Scholes Value” included in Section 3(e) of the Existing Warrants. As a result of the amendments to the related warrants (Series A, Series B and Series C) they were reclassified to equity as they no longer contained a strike price denominated in a foreign currency
First Purchase Agreement [Member]
Warrants to purchase up						7,750
First Purchase Agreement [Member] \| Series A Warrant [Member]
Warrants to purchase up						73,500
First Purchase Agreement [Member] \| Series B Warrant [Member]
Warrants to purchase up						73,500
Proceeds from warrant exercises \| $						$ 7,350,000
First Purchase Agreement [Member] \| Placement Agent Warrants [Member]
Warrants to purchase up						5,513
First Purchase Agreement [Member] \| Prefunded Warrant [Member]
Warrants to purchase up						65,750
First Purchase Agreement [Member] \| ADS and Ordinary Warrants [Member]
Lowest closing price of ordinary shares \| $ / shares						$ 100
First Purchase Agreement [Member] \| Prefunded Warrant and Ordinary Warrants [Member]
Lowest closing price of ordinary shares \| $ / shares						$ 99.98
Second Securities Purchase Agreement [Member]
Balance, shares					10,750
Second Securities Purchase Agreement [Member] \| Placement Agent Warrants [Member]
Warrants to purchase up					12,891
Second Securities Purchase Agreement [Member] \| Series C Warrant [Member]
Warrants to purchase up					171,875
Second Securities Purchase Agreement [Member] \| Prefunded Warrant [Member]
Warrants to purchase up					161,125
Second Securities Purchase Agreement [Member] \| ADS and Ordinary Warrants [Member]
Lowest closing price of ordinary shares \| $ / shares					$ 32
Second Securities Purchase Agreement [Member] \| Prefunded Warrant and Ordinary Warrants [Member]
Lowest closing price of ordinary shares \| $ / shares					31.98
Second Securities Purchase Agreement [Member] \| Warrant [Member]
Fair value of warrants price per share \| $ / shares					$ 6.40
Securities Purchase Agreement [Member]
Warrants to purchase up												1,675,000
Proceeds from warrant exercises \| $	$ 3,500,000
Balance, shares	75,000
Securities Purchase Agreement [Member] \| Placement Agent Warrants [Member]
Warrants to purchase up												131,250
Securities Purchase Agreement [Member] \| Series C Warrant [Member]
Warrants to purchase up												1,750,000
Securities Purchase Agreement [Member] \| ADS and Ordinary Warrants [Member]
Lowest closing price of ordinary shares \| £ / shares												£ 2.00
Securities Purchase Agreement [Member] \| Prefunded Warrant and Ordinary Warrants [Member]
Lowest closing price of ordinary shares \| £ / shares												£ 1.99
IPO [Member]
Fair value of warrants price per share \| $ / shares								$ 4,250
Proceeds from warrant exercises								$ 17,500,000	£ 12,800,000
Balance, shares								82,353	82,353